Track topics on Twitter Track topics that are important to you
Life Science company Bayer will host a full day workshop during The LAGRANT Foundation (TLF)’s 22nd Anniversary Scholarship Program at its facility in New Jersey on Wednesday, May 20, 2020. The workshop will be led by Raymond (Ray) F. Kerins Jr., Bayer’s senior vice president, head of Corporate Affairs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200115005239/en/
Ray Kerins, Senior Vice President of Corporate Affairs (Photo: Business Wire)
In his role, Kerins manages all communications, government relations, and philanthropy for the company. Previously, he was the vice president of external affairs and worldwide communications for pharmaceutical corporation Pfizer, where he oversaw internal and external communications for the company globally. Kerins is part of the host committee for TLF’s 22nd Anniversary Scholarship Program in 2020, which he was also part of during the 20th anniversary in 2018.
“This workshop with Bayer is an excellent addition to the 2020 scholarship program,” said TLF Chairman & CEO Mr. Kim L. Hunter. “I am looking forward to seeing what Ray and his team will have planned for what I’m positive will be an insightful and informative event.”
The event will include panel discussions and Q&A sessions with Bayer employees, talks led by Kerins, and a networking lunch. The workshop will round out TLF’s four-day scholarship program in which 50 ethnic minority students will receive $150,000 in scholarships and participate in career development and professional workshops with other marketing and advertising agencies in New York.
For more information on TLF, please visit www.lagrantfoundation.org.
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros. For more information, go to www.bayer.us.
About The LAGRANT Foundation (TLF)
Since its inception in 1998, The LAGRANT Foundation (TLF) has provided 576 scholarships and $2.57 million to continue its mission to increase the number of ethnic minorities in the fields of advertising, marketing and public relations. With the generous support of its major donors and supporters, TLF provides students with career & professional development workshops, scholarships, internships, entry-level positions and mentors to African American/Black, Alaska Native/Native American, Asian American/Pacific Islander and Hispanic/Latino undergraduate and graduate students.
Note to reporters and editors: “The” in The LAGRANT Foundation name is part of the Foundation’s legal name. Please do not drop the “The” or lowercase the “T.” When spelling “LAGRANT,” capitalize all letters. As an alternative, you can use the letters TLF in lieu of The LAGRANT Foundation.
Bayer Media Contact:
Bioscience - any of the sciences that deal with living organisms. The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Pfizer is a global pharmaceutical company, the largest in world based on annual sales. In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...